The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance
Open accessThe DOI matches its Crossref record; 189 of the 192 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Here we describe the consensus guideline methodology, summarise the evidence-based recommendations we provided to the World Health Organisation (WHO) for their consideration in the development of global guidance and present a narrative review on the management of anovulatory infertility in women with polycystic ovary syndrome (PCOS). OBJECTIVE AND RATIONALE: The aim of this paper was to present an evidence base for the management of anovulatory PCOS. SEARCH METHODS: The evidence to support providing recommendations involved a collaborative process for: (i) identification of priority questions and critical outcomes, (ii) retrieval of up-to-date evidence and exiting guidelines, (iii) assessment and synthesis of the evidence and (iv) the formulation of draft recommendations to be used for reaching consensus with a wide range of global stakeholders. For each draft recommendation, the methodologist evaluated the quality of the supporting evidence that was then graded as very low, low, moderate or high for consideration during consensus. OUTCOMES: and lifestyle therapy has failed. Carefully conducted and monitored pharmacological ovulation induction can achieve good cumulative pregnancy rates and multiple pregnancy rates can be minimized with adherence to recommended protocols. CC should be first-line pharmacotherapy for ovulation induction and letrozole can also be used as first-line therapy. Metformin alone has limited benefits in improving live birth rates. Gonadotropins and laparoscopic surgery can be used as second-line treatment. There is no clear evidence for efficacy of acupuncture or herbal mixtures in women with PCOS. For women with PCOS who fail lifestyle and ovulation induction therapy or have additional infertility factors, IVF can be used with the safer gonadotropin releasing hormone (GnRH) antagonist protocol. If a GnRH-agonist protocol is used, metformin as an adjunct may reduce the risk of ovarian hyperstimulation syndrome. Patients should be informed of the potential side effects of ovulation induction agents and of IVF on the foetus, and of the risks of multiple pregnancy. Increased risks for the mother during pregnancy and for the child, including the exacerbating impact of obesity on adverse outcomes, should also be discussed. WIDER IMPLICATIONS: This guidance generation and evidence-synthesis analysis has been conducted in a manner to be considered for global applicability for the safe administration of ovulation induction for anovulatory women with PCOS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The FAI, but also BMI, cycle history (oligomenorrhoea or amenorrhoea) and mean ovarian volume, were found to be criteria that influence the ovarian response to stimulation with clomiphene citrate medication (Imani et al., 2002;Balen et al., 2016).”
From Improvements in PCOS characteristics and phenotype severity during a randomized controlled lifestyle intervention (2021) · cites this paper as Balen et al., 2016
In the citing paper
“Indeed, hyperandrogenic women with PCOS were less likely to achieve pregnancy either naturally or after infertility treatment (Balen et al., 2016;De Vos et al., 2018).”
From Improvements in PCOS characteristics and phenotype severity during a randomized controlled lifestyle intervention (2021) · cites this paper as Balen et al., 2016
Citations
Cites
1 retracted
Nugent, D., Vanderkerchove, P., Hughes, E., Arnot, M., & Lilford, R. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000410.pub2 · Cited by 80
Retracted(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
Sjöström, L., Narbro, K., Sjöström, C. D., Karason, K., Larsson, B., Wedel, H., Lystig, T., Sullivan, M., Bouchard, C., Carlsson, B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066254 · Cited by 4,668
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetologia · doi:10.1007/s00125-012-2534-0 · Cited by 3,919
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824
Men at risk: occupation and male infertility
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,387
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132
Self-citationFauser, B. C. J. M., Tarlatzis, B. C., Rebar, R. W., Legro, R. S., Balen, A. H., Lobo, R., Carmina, E., Chang, J., Yildiz, B. O., Laven, J. S. E., et al. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.09.024 · Cited by 1,976
Self-citationDiamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Research works printed but not linked: 12
- 10.1093/humrep/ · doi:10.1093/humrep/
- 10.1093/humrep/ · doi:10.1093/humrep/
- 10.1530/EJE-14-0253 · DOI · Paper page
- 10.1093/humrep/ · doi:10.1093/humrep/
- 10.1093/humrep/ · doi:10.1093/humrep/
- Johnson T , Kaplan L , Ouyang P , Rizza R NAtional Institutes of Health . Evidence-based Methodology Workshop on Polycystic Ovary Syndrome. National Institutes of Health (NIH) Evidence-based Methodology Workshop 2012.
- 10.1093/humrep/ · doi:10.1093/humrep/
- 10.1093/humrep/ · doi:10.1093/humrep/
- Morley LC , Tang T , Yasmin E , Lord JM , Norman RJ , Balen AH. Insulin-sensitising drugs (metformin, rosaglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev In press.
- Teede, 2013, Longitudinal Weight Gain in Women Identified with Polycystic Ovary Syndrome: Results of an Observational Study in Young Women Obesity (Silver Spring), 21, 1526
- 10.1093/humrep/ · doi:10.1093/humrep/
- 10.1210/jc.84.10.3666 · DOI · Paper page
Cited by
Polycystic Ovary Syndrome: Definition, Aetiology, Diagnosis and Treatment
Escobar-Morreale, H. F. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.24 · Cited by 2,083
Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., & the International PCOS Network (2018) · Clinical Endocrinology · doi:10.1111/cen.13795 · Cited by 1,823
Self-citationTeede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., International PCOS Network, Andersen, M., et al. (2018) · Human Reproduction · doi:10.1093/humrep/dey256 · Cited by 1,593
Self-citationTeede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., Andersen, M., Azziz, R., et al. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.05.004 · Cited by 1,325
Self-citationBlackmore, R., Boyle, J. A., Fazel, M., Ranasinha, S., Gray, K. M., Fitzgerald, G., Misso, M., & Gibson-Helm, M. (2020) · PLOS Medicine · doi:10.1371/journal.pmed.1003337 · Cited by 949
Self-citation
Metadata
- Authors
- Balen, A. H., Morley, L. C., Misso, M., Franks, S., Legro, R. S., Wijeyaratne, C. N., Stener-Victorin, E., Fauser, B. C. J. M., Norman, R. J., & Teede, H.
- Affiliations
- Leeds Teaching Hospitals NHS Trust (GB)
- Monash Medical Centre (AU)
- Hammersmith Hospital (GB)
- Pennsylvania State University (US)
- University of Colombo (LK)
- University Medical Center Utrecht (NL)
- The University of Adelaide (AU)
- Corresponding author
- Balen, Adam H.
- ORCID
- Venue
- Human Reproduction Update
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-08-10
- Volume
- 22
- Issue
- 6
- Pages
- 687-708
- ISSN
- 1355-4786 (ISSN-L)
- 1460-2369
- OpenAlex
- W2481420451
- Cited by
- 705
- References
- 192
- Citations by year
- 2026: 52 · 2025: 73 · 2024: 83 · 2023: 101 · 2022: 113 · 2021: 88 · 2020: 57 · 2019: 54 · 2018: 53 · 2017: 28 · 2016: 1
- FWCI
- 6.51
- Type
- journal article
- Language
- en
- Open access
- green
- dspace.library.uu.nl
- Licence
- other-oa
- Locations
- Human Reproduction Update (publishedVersion)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- Funders
- LCM
- MM
- AHB
- BJCMF
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Keywords
- polycystic ovary syndrome, anovulatory infertility, ovulation induction, clomiphene citrate, letrozole, metformin, gonadotropins, laparoscopic ovarian drilling, in vitro fertilization, GnRH antagonist protocol, ovarian hyperstimulation syndrome, multiple pregnancy, lifestyle therapy, acupuncture, herbal combination, pregnancy outcomes
- MeSH terms
- Healthy Lifestyle, Letrozole, Anovulation, Clomiphene, Female, Fertility Agents, Female, Fertilization in Vitro, Gonadotropins, Humans, Infertility, Female, Metformin, Nitriles, Obesity, Ovulation, Ovulation Induction, Polycystic Ovary Syndrome, Pregnancy, Receptors, Gonadotropin, Triazoles, Ovarian Hyperstimulation Syndrome, Practice Guidelines as Topic, Consensus, Aromatase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. https://app.cochat.ai/papers/10.1093/humupd/dmw025
- The paper
- Balen, A. H., Morley, L. C., Misso, M., Franks, S., Legro, R. S., Wijeyaratne, C. N., Stener-Victorin, E., Fauser, B. C. J. M., Norman, R. J., & Teede, H. (2016). The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Human Reproduction Update. https://doi.org/10.1093/humupd/dmw025
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.